Anesthesiology, Pain Medicine · Wexford, PA
NPI
1700913456
Since 2007
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7000 Stonewood Dr, Suite 151
Wexford, PA, 15090
Phone (724) 933-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
2,082 services
Medicare patients, 2024
286
Average age 69
Drug cost, 2024
$606K
3,359 prescriptions
Company payments, 2025
$133
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark R Lodico was code J0702 (injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg), 462 times for 83 patients. In total Mark R Lodico billed 2,082 services in 51 codes, and Medicare paid $124K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-24.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 462 | 83 | $5.37 | $2,482 |
| J2250 Injection, midazolam hydrochloride, per 1 mg | Office | 337 | 53 | $0.11 | $36.75 |
| 99214 Office E&M - Established | Office | 243 | 128 | $77.62 | $19K |
| 80307 Drug Tests | Office | 106 | 100 | $60.90 | $6,455 |
| 95886 Electrical Nerve Conductivity | Office | 98 | 46 | $61.23 | $6,000 |
| 64483 Nerve Block Injection - Back | Office | 94 | 69 | $218.52 | $21K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 57 | 54 | $194.77 | $11K |
| 64493 Nerve Block Injection - Back | Office | 39 | 23 | $112.08 | $4,371 |
| 99152 Anesthesia | Office | 39 | 32 | $33.51 | $1,307 |
| 64494 Nerve Block Injection - Back | Office | 38 | 22 | $57.02 | $2,167 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 35 | 32 | $0.11 | $3.8 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 31 | 29 | $112.14 | $3,476 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 29 | 26 | $292.63 | $8,486 |
| 64484 Nerve Block Injection - Back | Office | 28 | 22 | $75.08 | $2,102 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 27 | 25 | $159.54 | $4,308 |
By year: 2022 $146K for 2,591 services; 2023 $145K for 2,096 services; 2024 $124K for 2,082 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 106 | 100 | $60.90 | $6,455 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 57 | 54 | $194.77 | $11K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 31 | 29 | $112.14 | $3,476 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 21 | 20 | $147.73 | $3,102 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark R Lodico prescribed most often to Medicare patients was Morphine Sulfate Er (Morphine Sulfate), with 658 prescriptions and refills. In total Mark R Lodico wrote 3,359 Medicare prescriptions that cost $606K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Morphine Sulfate Er Morphine Sulfate | 658 | 661 | 275 | $19K |
| Xtampza Er Oxycodone Myristate | 469 | 470 | 206 | $308K |
| Pregabalin Generic | 432 | 454 | 158 | $13K |
| Gabapentin Generic | 344 | 371 | 133 | $6,265 |
| Fentanyl Generic | 277 | 277 | 79 | $26K |
| Celecoxib Generic | 156 | 166 | 67 | $3,215 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 155 | 155 | 122 | $637 |
| Buprenorphine Generic | 137 | 137 | 71 | $35K |
| Oxycontin Oxycodone Hcl | 121 | 121 | 54 | $82K |
| Tramadol Hcl Er Tramadol Hcl | 79 | 79 | 42 | $5,491 |
| Meloxicam Generic | 72 | 74 | 29 | $591 |
| Hysingla Er Hydrocodone Bitartrate | 60 | 60 | 26 | $51K |
| Tramadol Hcl Generic | 51 | 51 | 29 | $241 |
| Duloxetine Hcl Generic | 46 | 66 | 17 | $558 |
| Etodolac Generic | 32 | 32 | 12 | $1,008 |
Brand drugs: 760 claims; generic drugs: 2,599 claims; opioid claims: 2,091.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark R Lodico $133 ($133 in general payments such as food, travel and fees) from 3 companies. The largest payer was Collegium Pharmaceutical, Inc. with $96.26.
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. COLL | 5 | $96.26 |
| TerSera Therapeutics LLC | 1 | $23.09 |
| SPR Therapeutics, Inc | 1 | $13.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.